IMMUNE CHECKPOINT INHIBITOR
Clinical trials for IMMUNE CHECKPOINT INHIBITOR explained in plain language.
Never miss a new study
Get alerted when new IMMUNE CHECKPOINT INHIBITOR trials appear
Sign up with your email to follow new studies for IMMUNE CHECKPOINT INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gut radiation + immunotherapy: a new hope for tough esophageal cancers?
Disease control OngoingThis study is testing a new combination treatment for people with esophageal cancer that is difficult or impossible to remove with surgery right away. The goal is to see if adding a very low dose of radiation to the intestines to an immunotherapy and chemotherapy regimen can shri…
Matched conditions: IMMUNE CHECKPOINT INHIBITOR
Phase: PHASE2 • Sponsor: Chuangzhen Chen • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope to slow advanced prostate cancer
Disease control OngoingThis study is testing whether adding a new immunotherapy drug called lorigerlimab to standard chemotherapy (docetaxel) can help men with advanced prostate cancer live longer without their cancer getting worse. About 150 men whose cancer has spread and stopped responding to hormon…
Matched conditions: IMMUNE CHECKPOINT INHIBITOR
Phase: PHASE2 • Sponsor: MacroGenics • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC